Salsabeel Mohammad Sabi

Mrs. Salsabeel Mohammad Sabi

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2024 in Diabetes, Metabolic Syndrome and Obesity
Verified
Journal Article
Open access
PDF file
SSSalsabeel Mohammad Sabi
Salsabeel Mohammad Sabi
RARoaa K Alzreqat
Roaa K Alzreqat
AAAmmar Almaaytah
Ammar Almaaytah
MMMajed M Masaadeh
Majed M Masaadeh
AAAhmad Khaled Abualhaijaa
Ahmad Khaled Abualhaijaa
Hyperinsulinemic Hypoglycemia (HH) is a rare condition that affects newborn children in the postnatal period, represented by dangerously low levels of blood glucose in a persistent manner, which puts the baby at high risk of multiple issues, especially regarding the brain cells if the baby does not take the appropriate medication or have the correct diagnosis. Hyperinsulinemic Hypoglycemia can happen due to an active or inactive mutation in 16 genes responsible for glucose metabolism and insulin secretion (GLUD1, GCK, SLC16A1, HK1, CACNA1D, KCNJ11, ABCC8, FOXA2, HNF1A, HNF4A, HADH, PGM1, UCP2, KCNQ1, PMM2, EIF2S3). These mutations can take place in many forms, either defused or local, affecting several or all pancreatic beta cells respectively. This review summarizes genetic variations diagnosis and treatment of Hyperinsulinemic Hypoglycemia.

10 June 2025 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
YTYara Al Tall
Yara Al Tall
YAYasmeen Alkurdi
Yasmeen Alkurdi
NANid'a Alshraiedeh
Nid'a Alshraiedeh
SSSalsabeel Mohammad Sabi
Salsabeel Mohammad Sabi
Background/Objectives: The rise of antibiotic-resistant bacteria presents a major global health challenge, highlighting the need for novel antimicrobial agents such as antimicrobial peptides (AMPs). AMPs are promising due to their broad-spectrum activity, membrane-disruptive mechanisms, and low development of resistance. This study aimed to design and evaluate novel AMPs derived from a synthetic parent peptide (PEP-38). Methods: Novel peptides were designed using bioinformatics tools, including CAMPR3 and Peptide Ranker. Their antimicrobial potential was validated through in vitro assays, including bacterial susceptibility, antibiofilm activity, cytotoxicity, hemolysis, and time–kill kinetics. Results: Among the designed peptides, Hel-4K-12K showed potent activity against both Gram-positive and Gram-negative bacteria, with MICs ranging from 3.125 to 6.25 µM. It also effectively eradicated biofilms of resistant Staphylococcus aureus at an MBEC of 6.25 µM. Time–kill assays confirmed rapid bactericidal action, achieving complete bacterial elimination within one hour at its MIC. Moreover, Hel-4K-12K exhibited low toxicity toward mammalian MDCK cells (>82% viability at MIC) and minimal hemolytic activity on human erythrocytes. Conclusions: Hel-4K-12K demonstrates strong antibacterial and antibiofilm activities with a favorable safety profile, indicating its potential as a therapeutic candidate for treating infections caused by resistant bacteria. These findings support further development of this peptide as a basis for new antimicrobial drug strategies. In addition to its promising in vitro profile, future studies will investigate Hel-4K-12K in animal models and evaluate strategies for attaining stable formulations, such as peptide encapsulation or PEGylation. These steps are critical to ensure its therapeutic viability in systemic applications.

25 March 2025 in Pharmacia
Verified
Journal Article
Open access
PDF file
BABatool H. Alfurjani
Batool H. Alfurjani
SSSalsabeel Mohammad Sabi
Salsabeel Mohammad Sabi
AAAmmar Almaaytah
Ammar Almaaytah
MMMajd M. Masadeh
Majd M. Masadeh
AAAhmad K. Abualhaijaa
Ahmad K. Abualhaijaa
Helicobacter pylori infects more than 50% of the human population worldwide. Persistence and colonization of this bacterium in the host result in genetic and epigenetic alteration and intra-complicated reactions that enhance innate and adaptive immune responses, which lead to the development of several gastrointestinal illnesses and increase the risk for gastric cancer progression. Even the World Health Organization (WHO) classified a bacterium in the first group of carcinogens; also, it has been associated with multiple extra gastric implications such as autoimmune disease and cardiovascular disease, thereby being considered a highly infectious pathogen and a critical health problem globally. Detection of the infection facilitates prognosis for suitable treatment that enhances eradication of this bacterium to prevent further implication. The aim of this review is to convey several aspects related to the Helicobacter pylori infection, to understand and clarify the epigenetic changes, host immune response, and the pathogenicity of multiple virulence factors involved in the infection, as well as diagnostic options, the fundamental strategy of treatment and the rate of reinfection among variable individuals.